IP Verse

Substituted Tetrahydrofurans As Modulators Of Sodium Channels

Patent No. EP4069691 (titled "Substituted Tetrahydrofurans As Modulators Of Sodium Channels") was filed by Vertex Pharmaceuticals Incorporated on Dec 4, 2020. The application was issued on Sep 18, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BARDEHLE PAGENBERGJun 17, 2025BARDEHLE PAGENBERG SL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4069691

VERTEX PHARMACEUTICALS INCORPORATED
Application Number
EP20825397A
Filing Date
Dec 4, 2020
Status
Granted And Under Opposition
Aug 15, 2024
Publication Date
Sep 18, 2024
External Links
Slate, Register , Google Patents